{"id":"https://openalex.org/W3014464491","doi":"https://doi.org/10.1111/dom.14048","title":"Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9\u201039) for treatment of post\u2010bariatric hypoglycaemia","display_name":"Safety, efficacy and pharmacokinetics of repeat subcutaneous dosing of avexitide (exendin 9\u201039) for treatment of post\u2010bariatric hypoglycaemia","alternate_titles":[],"publication_year":2020,"publication_date":"2020-05-04","ids":{"openalex":"https://openalex.org/W3014464491","doi":"https://doi.org/10.1111/dom.14048","mag":"3014464491","pmid":"https://pubmed.ncbi.nlm.nih.gov/32250530"},"language":"en","primary_location":{"id":"doi:10.1111/dom.14048","doi":"https://doi.org/10.1111/dom.14048","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14048","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3014464491"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084531153","display_name":"Marilyn J. Tan","orcid":"https://orcid.org/0000-0002-6651-4691","observed_orcids":["https://orcid.org/0000-0002-6651-4691"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Marilyn Tan","raw_affiliation_strings":["Department of Medicine, Division of Endocrinology, Stanford University School of Medicine, Stanford, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-6651-4691","affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Endocrinology, Stanford University School of Medicine, Stanford, California, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112922884","display_name":"Cindy A. Lamendola","orcid":"https://orcid.org/0000-0002-1516-5209","observed_orcids":["https://orcid.org/0000-0002-1516-5209"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Cynthia Lamendola","raw_affiliation_strings":["Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072755092","display_name":"Roger Luong","orcid":"https://orcid.org/0000-0001-8505-4654","observed_orcids":["https://orcid.org/0000-0001-8505-4654"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roger Luong","raw_affiliation_strings":["Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California, USA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045366155","display_name":"Tracey McLaughlin","orcid":"https://orcid.org/0000-0002-4829-8649","observed_orcids":["https://orcid.org/0000-0002-4829-8649"]},"institutions":[{"id":"https://openalex.org/I4210138383","display_name":"Eiger Biopharmaceuticals (United States)","ror":"https://ror.org/039945b55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210138383"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tracey McLaughlin","raw_affiliation_strings":["Eiger BioPharmaceuticals, Consultant, Palo Alto, California, USA"],"raw_orcid":"https://orcid.org/0000-0002-4829-8649","affiliations":[{"raw_affiliation_string":"Eiger BioPharmaceuticals, Consultant, Palo Alto, California, USA","institution_ids":["https://openalex.org/I4210138383"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000945915","display_name":"Colleen M. Craig","orcid":"https://orcid.org/0000-0003-1308-6440","observed_orcids":["https://orcid.org/0000-0003-1308-6440"]},"institutions":[{"id":"https://openalex.org/I4210138383","display_name":"Eiger Biopharmaceuticals (United States)","ror":"https://ror.org/039945b55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210138383"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Colleen Craig","raw_affiliation_strings":["Eiger BioPharmaceuticals, Consultant, Palo Alto, California, USA"],"raw_orcid":"https://orcid.org/0000-0003-1308-6440","affiliations":[{"raw_affiliation_string":"Eiger BioPharmaceuticals, Consultant, Palo Alto, California, USA","institution_ids":["https://openalex.org/I4210138383"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5084531153"],"corresponding_institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":5.4121,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.96909918,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":98},"biblio":{"volume":"22","issue":"8","first_page":"1406","last_page":"1416"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10569","display_name":"Bariatric Surgery and Outcomes","score":0.6445000171661377,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10569","display_name":"Bariatric Surgery and Outcomes","score":0.6445000171661377,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.16279999911785126,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.12620000541210175,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exendin-9-39","display_name":"exendin-9-39","score":0.9449999928474426},{"id":"https://openalex.org/keywords/subcutaneous-dosing","display_name":"subcutaneous dosing","score":0.7429999709129333},{"id":"https://openalex.org/keywords/multiple-ascending-dose","display_name":"multiple ascending dose","score":0.48500001430511475},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9300000071525574},{"id":"https://openalex.org/keywords/hyperinsulinemic-hypoglycemia","display_name":"hyperinsulinemic hypoglycemia","score":0.8659999966621399},{"id":"https://openalex.org/keywords/lyophilized-formulation","display_name":"lyophilized formulation","score":0.6620000004768372},{"id":"https://openalex.org/keywords/liquid-formulation","display_name":"liquid formulation","score":0.9520000219345093},{"id":"https://openalex.org/keywords/bariatric-surgery","display_name":"bariatric surgery","score":0.7139999866485596},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.7300000190734863}],"concepts":[{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.862906813621521},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8533715605735779},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8202265501022339},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8008622527122498},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5087528824806213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3994904160499573},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.38979852199554443},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.32035332918167114}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049088","descriptor_name":"Bariatrics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/dom.14048","doi":"https://doi.org/10.1111/dom.14048","is_oa":false,"landing_page_url":"https://doi.org/10.1111/dom.14048","pdf_url":null,"source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:32250530","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32250530","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W128983826","https://openalex.org/W1507814807","https://openalex.org/W1558182564","https://openalex.org/W1579521480","https://openalex.org/W1942344902","https://openalex.org/W1982683392","https://openalex.org/W1998723338","https://openalex.org/W2002628772","https://openalex.org/W2003725355","https://openalex.org/W2012289105","https://openalex.org/W2014019554","https://openalex.org/W2015020820","https://openalex.org/W2019955082","https://openalex.org/W2055179027","https://openalex.org/W2057322700","https://openalex.org/W2058293677","https://openalex.org/W2062709476","https://openalex.org/W2093962199","https://openalex.org/W2099409010","https://openalex.org/W2111242088","https://openalex.org/W2114161811","https://openalex.org/W2138474841","https://openalex.org/W2146581079","https://openalex.org/W2160234571","https://openalex.org/W2168804523","https://openalex.org/W2179286416","https://openalex.org/W2435458196","https://openalex.org/W2561646992","https://openalex.org/W2566696477","https://openalex.org/W2579010290","https://openalex.org/W2601397671","https://openalex.org/W2744291436","https://openalex.org/W2784732818","https://openalex.org/W2785543849","https://openalex.org/W2790835086","https://openalex.org/W2800891187","https://openalex.org/W2896050782","https://openalex.org/W2912094716","https://openalex.org/W2947147808","https://openalex.org/W2954694474","https://openalex.org/W2982798086","https://openalex.org/W2995420665","https://openalex.org/W6650153860"],"related_works":["https://openalex.org/W2944651787","https://openalex.org/W3130101367","https://openalex.org/W4307805272","https://openalex.org/W4410939776","https://openalex.org/W2744291436","https://openalex.org/W4415451166","https://openalex.org/W7213312975","https://openalex.org/W7093309846","https://openalex.org/W3080194975","https://openalex.org/W2561646992"],"abstract_inverted_index":{"AIM:":[0],"To":[1],"evaluate":[2],"the":[3,78,137,242],"safety,":[4,81],"efficacy":[5,82],"and":[6,51,83,128,155,187,203,220,245],"pharmacokinetics":[7],"of":[8,11,14,62,66,80,95,104,122,139,213,237],"repeat":[9,117],"dosing":[10,123],"two":[12],"formulations":[13,226],"subcutaneous":[15],"(SC)":[16],"avexitide":[17,70,96,135,176,217,239],"(exendin":[18],"9-39)":[19],"in":[20,150,194,200,207],"patients":[21,232],"with":[22,39,49,133,147,233],"post-bariatric":[23],"hypoglycaemia":[24,142,248],"(PBH).":[25],"METHODS:":[26],"In":[27,231],"this":[28],"phase":[29],"2,":[30],"multiple-ascending-dose":[31],"study":[32],"conducted":[33],"at":[34,100,143,169],"Stanford":[35],"University,":[36],"19":[37,113],"women":[38],"PBH":[40],"underwent":[41,115],"a":[42,90,101,116,191,197,204,255],"baseline":[43],"oral":[44],"glucose":[45,151,170,195,243],"tolerance":[46],"test":[47],"(OGTT),":[48],"metabolic":[50],"symptomatic":[52,127,140],"assessments.":[53],"Fourteen":[54],"were":[55,227],"then":[56,88],"sequentially":[57],"assigned":[58],"to":[59,124],"receive":[60],"one":[61],"four":[63],"ascending-dose":[64],"levels":[65],"twice-daily":[67,235],"lyophilized":[68],"(Lyo)":[69],"by":[71,97],"SC":[72,98,238],"injection":[73,99],"for":[74,109,258],"3":[75,110,121],"days.":[76,111],"On":[77],"basis":[79],"tolerability,":[84],"five":[85],"additional":[86],"participants":[87,114],"received":[89],"novel":[91],"liquid":[92],"formulation":[93],"(Liq)":[94],"fixed":[102],"dose":[103,145],"30":[105,177],"mg":[106,160,178],"twice":[107,161,179],"daily":[108,162,180],"All":[112],"OGTT":[118],"on":[119,188],"day":[120],"quantify":[125],"metabolic,":[126],"pharmacokinetic":[129],"responses.":[130],"RESULTS:":[131],"Treatment":[132],"Lyo":[134,216],"reduced":[136],"magnitude":[138],"hyperinsulinaemic":[141],"all":[144],"levels,":[146],"dose-dependent":[148],"improvements":[149],"nadir,":[152,196],"insulin":[153],"peak":[154,201],"symptom":[156,209],"score;":[157],"doses":[158,212],"\u226520":[159],"did":[163,181],"not":[164,182],"require":[165,183],"glycaemic":[166,185],"rescue":[167,250],"(administered":[168],"<2.8":[171],"mmol/L).":[172],"Participants":[173],"receiving":[174],"Liq":[175,214],"any":[184],"rescue,":[186],"average":[189],"achieved":[190],"47%":[192,205],"increase":[193],"67%":[198],"reduction":[199,206],"insulin,":[202],"overall":[208],"score.":[210],"Equivalent":[211],"versus":[215],"yielded":[218],"higher":[219],"more":[221],"sustained":[222],"plasma":[223],"concentrations.":[224],"Both":[225],"well":[228],"tolerated.":[229],"CONCLUSIONS:":[230],"PBH,":[234],"administration":[236],"effectively":[240],"raised":[241],"nadir":[244],"prevented":[246],"severe":[247],"requiring":[249],"intervention.":[251],"Avexitide":[252],"may":[253],"represent":[254],"viable":[256],"therapy":[257],"PBH.":[259]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3014464491","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2020-04-10T00:00:00"}
